AXS Investments’s Gilead Sciences GILD Stock Holding History

AXS Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,560	Closed	-$1.3M	–	175
2025 Q1	$1.3M	Buy	+11,560	New	+$1.19M	0.36%	126
2024 Q2	–	Sell	-2,895	Closed	-$212K	–	256
2024 Q1	$212K	Buy	2,895 +845	+41%	+$65K	0.05%	277
2023 Q4	$166K	Sell	2,050 -295	-13%	-$23K	0.04%	304
2023 Q3	$176K	Buy	2,345 +385	+20%	+$29.6K	0.05%	270
2023 Q2	$151K	Sell	1,960 -954	-33%	-$76.1K	0.04%	279
2023 Q1	$242K	Buy	2,914 +560	+24%	+$46.4K	0.08%	202
2022 Q4	$202K	Sell	2,354 -1,736	-42%	-$137K	0.07%	196
2022 Q3	$252K	Buy	+4,090	New	+$258K	0.1%	190
2022 Q1	–	Sell	-2,840	Closed	-$206K	–	159
2021 Q4	$206K	Buy	+2,840	New	+$196K	0.05%	163
2021 Q3	–	Sell	-4,475	Closed	-$308K	–	150
2021 Q2	$308K	Buy	+4,475	New	+$299K	0.09%	139

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AXS Investments's GILD Position: Q2 2025 in Review

AXS Investments sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 11,560 shares — an estimated $1.3M sold.

AXS Investments first reported a position in GILD in Q2 2021 and held it in 10 quarters. The position peaked at $1.3M in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

AXS Investments reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
AXS Investments sold 11,560 Gilead Sciences shares in Q2 2025, an estimated $1.3M.
AXS Investments first reported a position in Gilead Sciences in Q2 2021 and held it in 10 quarters.
AXS Investments's Gilead Sciences position peaked at $1.3M in Q1 2025.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on AXS Investments's 13F filing for Q2 2025, filed 11 Aug 2025.